Alembic Pharmaceuticals has received final USFDA approval for its abbreviated new drug application (ANDA) travoprost ophthalmic solution USP, 0.004%. The approved ANDA is therapeutically equivalent […]
Novadoz Pharmaceuticals, the US based sales & marketing affiliate for MSN Labs has received USFDA approval for their generic version of febuxostat 40mg and 80mg […]
Indoco Remedies has received final USFDA approval for febuxostat tablets 40 mg and 80 mg from US Food and Drug Administration (FDA), which is therapeutically […]
Lupin India has received the USFDA approval to market its Betamethasone Dipropionate ointment (augmented), in the American market. The corticosteroid drug is prescribed for the […]
Alembic Pharmaceuticals has received USFDA approvals for its generic Deferasirox tablets used for treatment of chronic iron overload due to blood transfusions in patients over […]
Glenmark Pharmaceuticals has received final USFDA for metformin hydrochloride tablets used in the management of type-two diabetes.The drug metformin hydrochloride extended release tablets USP, 500 […]
Zydus Cadila has received USFDA approval to market Isosorbide Dinitrate tablets used to prevent attacks of chest pain. The company also received USFDA approval for […]
Granules India has received USFDA approval for Fexofenadine Hydrochloride tablets, used to treat allergy symptoms. The approved drug is bio-equivalent to the reference listed drug […]
Lupin has received USFDA approval for its generic Divalproex Sodium extended-release tablets to market the same in the American market. The drug Divalproex Sodium extended-release […]
Cadila Healthcare has received USFDA approval for Haloperidol Decanoate injection used in treatment of schizophrenia. It is also used in the treatment of schizophrenia and […]
Copyright © 2020 | Ibis Research Information Services Pvt Ltd Privacy Policy and Terms of Use